Advertisement

Protective Effect of Ganoderma (Lingzhi) on Radiation and Chemotherapy

  • Lihua Chen
  • Abudumijiti Abulizi
  • Min LiEmail author
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1182)

Abstract

Radiation and chemotherapy are common and mainstay treatments for cancer patients. But they are also usually associated with some toxicity and side effects in most of the patients. Ganoderma (Lingzhi) is considered as a major kind of complementary/alternative medicine and used to prevent the adverse effects caused by radiation and chemotherapy. This chapter reviewed the protective effects of Ganoderma (Lingzhi) on radiation and chemotherapy, including the preventive effects on myelosuppression, intestinal injury, nephrotoxicity, cardiovascular toxicity, and other side effects. Both basic researches and clinical studies of Ganoderma (Lingzhi) in preventing side effects induced by radiation and chemotherapy were reviewed.

Keywords

Ganoderma Lingzhi Polysaccharides Polysaccharide peptides Myelosuppression Intestinal mucosal immune 

References

  1. 1.
    Kovac AL (2003) Benefits and risks of newer treatments for chemotherapy -induced and postoperative nausea and vomiting. Drug Safety 26(4):227–259PubMedCrossRefGoogle Scholar
  2. 2.
    Cui JJ, Yuan JF, Zhang ZQ (2010) Anti-oxidation activity of the crude polysaccharides isolated from Polygonum Cillinerve (Nakai) Ohwi in immunosuppressed mice. J Ethnopharmacol 132(2):512–517PubMedCrossRefGoogle Scholar
  3. 3.
    Mujic A, Grdovic N, Mujić I, Mihailović M, Živković J, Poznanović G, Vidaković M (2011) Anti-oxidative effects of phenolic extracts from chestnut leaves, catkins and spiny burs in streptozotocin-treated rat pancreatic beta-cells. Food Chem 125(3):841–849CrossRefGoogle Scholar
  4. 4.
    Devipriya N, Nagarajan AR, Sudheer M, Menon VP (2008) Quercetin ameliorates gamma radiation-induced DNA damage and biochemical changes in human peripheral blood lymphocytes. Mutat Res 654(1):1–7PubMedCrossRefGoogle Scholar
  5. 5.
    Tagliaferri M, Cohen I, Tripathy D (2001) Complementary and alternative medicine in early stage breast cancer. Semin Oncol 28(1):121–134PubMedCrossRefGoogle Scholar
  6. 6.
    Lindequist U, Niedermeyer THJ, Julich WD (2005) The pharmacological potential of mushrooms. eCAM 2(3):285–299PubMedGoogle Scholar
  7. 7.
    Wasser SP (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60(3):258–274PubMedCrossRefGoogle Scholar
  8. 8.
    Zaidman BZ, Yassin M, Mahajna J, Wasser SP (2005) Medicinal mushroom. modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67(4):453–464PubMedCrossRefGoogle Scholar
  9. 9.
    Sheena N, Lakshmi B, Janardhanan KK (2005) Therapeutic potential of Ganoderma lucidum (Fr.) P. Karst. Nat Prod Rad 4(5):382Google Scholar
  10. 10.
    Pillai TG, Salvi VP, Maurya DK, Nair CKK, Janardhanan KK (2006) Prevention of radiation-induced damages by aqueous extract of Ganoderma lucidum occurring in southern parts of India. Curr Sci 91(3):341Google Scholar
  11. 11.
    Mego M, Holec V, Drgona L, Hainova K, Ciernikova S, Zajac V (2013) Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement Ther Med 21(6):712–723PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Soccol CR, Bissoqui LY, Rodrigues C, Rubel R, Sella SR, Leifa F, de Souza VL, Soccol VT (2016) Pharmacological properties of biocompounds from spores of the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (Agaricomycetes): a review. Int J Med Mushrooms 18(9):757–767PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18(13):2505–2514PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Lin ZB, Zhang HN (2004) Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin 25(11):1387–1395PubMedGoogle Scholar
  15. 15.
    Cao Y, Xu X, Liu S, Huang L, Gu J (2018) Ganoderma: a cancer immunotherapy review. Front Pharmacol 9:1217PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Lin ZB, Zhang ZL, Lin HR, Wu YC, Ruan Y, Cong Z, Cai ZJ (1980) Preliminary study on the anti-radiation effects of Ganoderma lucidum. Sci Bull (Ke Xue Tong Bao) 4:187–184Google Scholar
  17. 17.
    Ahlmann M, Hempel G (2016) The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy. Cancer Chemother Pharmacol 78(4):661–671PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Zhu XL, Liu JH, Li WD, Lin ZB (2012) Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides. Front Pharmacol 3:20PubMedCentralCrossRefGoogle Scholar
  19. 19.
    Smina TP, Maurya DK, Devasagayam TP, Janardhanan KK (2015) Protection of radiation induced DNA and membrane damages by total triterpenes isolated from Ganoderma lucidum (Fr.) P. Karst. Chem Biol Interact 233:1–7CrossRefGoogle Scholar
  20. 20.
    Smina TP, De S, Devasagayam TP, Adhikari S, Janardhanan KK (2011) Ganoderma lucidum total triterpenes prevent radiation-induced DNA damage and apoptosis in splenic lymphocytes in vitro. Mutat Res 726(2):188–194CrossRefGoogle Scholar
  21. 21.
    Pillai TG, Nair CK, Janardhanan KK (2008) Polysaccharides isolated from Ganoderma lucidum occurring in Southern parts of India, protects radiation induced damages both in vitro and in vivo. Environ Toxicol Pharmacol 26(1):80–85PubMedCrossRefGoogle Scholar
  22. 22.
    Pillai TG, Uma DP (2013) Mushroom beta glucan: potential candidate for post irradiation protection. Mutat Res 751(2):109–115PubMedCrossRefGoogle Scholar
  23. 23.
    Pillai TG, Maurya DK, Salvi VP, Janardhanan KK, Nair CK (2014) Fungal beta glucan protects radiation induced DNA damage in human lymphocytes. Ann Transl Med 2(2):13PubMedPubMedCentralGoogle Scholar
  24. 24.
    Zhao W, Jiang X, Deng W, Lai Y, Wu M, Zhang Z (2012) Antioxidant activities of Ganoderma lucidum polysaccharides and their role on DNA damage in mice induced by cobalt-60 gamma-irradiation. Food Chem Toxicol 50(2):303–309PubMedCrossRefGoogle Scholar
  25. 25.
    Liu GJ, Li J, Chen LL, Jiang ZJ, Liu PQ, Chen JW, Guo LB (2017) The efficacy enhancing and toxicity reducing of Ganoderma lucidum spore oil emulsion to mice undergoing chemotherapy. Electron J Metab Nutr Cancer 4(1):60–66Google Scholar
  26. 26.
    Chen CH, Fang TH, Xu L, Zhou LL, Jia M (2008) Toxin-attenuating and the efficacy-enhancing effect of Compound Lingzhi Baozi Oil on S180 tumor-bearing mice after chemotherapy. J Nanjing TCM Univ 24(2):127–129Google Scholar
  27. 27.
    Yu S, Wu S, Liu J, Han C, Wei L (1997) An experimental study on the effects of lingzhi spore on the immune function and 60Co radioresistance in mice. Zhongguo Zhong Yao Za Zhi 22(10):625–626PubMedGoogle Scholar
  28. 28.
    Kashimoto N, Ishii S, Myojin Y, Ushijima M, Hayama M, Watanabe H (2010) A water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia attenuates the small intestinal injury induced by anti-cancer drugs. Oncol Lett 1(1):63–64PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Kubo N, Myojin Y, Shimamoto F, Kashimoto N, Kyo E, Kamiya K, Watanabe H (2005) Protective effects of a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia and Agaricus blazei murill against X-irradiation in B6C3F1 mice: Increased small intestinal crypt survival and prolongation of average time to animal death. Int J Mol Med 15(3):401–406Google Scholar
  30. 30.
    Li CH, Ko JL, Ou CC, Lin WL, Yen CC, Hsu CT, Hsiao YP (2019) The protective role of GMI, an immunomodulatory protein from Ganoderma microsporum, on 5-fluorouracil-induced oral and intestinal Mucositis. Integr Cancer Ther 18:1871052227CrossRefGoogle Scholar
  31. 31.
    Chen LH, Lin ZB, Li WD (2011) Ganoderma lucidum polysaccharides reduce methotrexate- induced small intestinal damage in mice via induction of epithelial cell proliferation and migration. Acta Pharmacol Sin 32(12):1505–1512PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Husain K, Morris C, Whitworth C, Trammell GL, Rybak LP, Somani SM (1998) Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system. Mol Cell Biochem 178(1-2):127–133PubMedCrossRefGoogle Scholar
  33. 33.
    Sheena N, Ajith TA, Janardhanan KK (2003) Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medicinal mushroom occurring in South India. Curr Sci India 85(4):478–482Google Scholar
  34. 34.
    Pillai TG, John M, Sara TG (2011) Prevention of cisplatin induced nephrotoxicity by terpenes isolated from Ganoderma lucidum occurring in Southern Parts of India. Exp Toxicol Pathol 63(1-2):157–160PubMedCrossRefGoogle Scholar
  35. 35.
    Yan YM, Wang XL, Zhou LL, Zhou FJ, Li R, Tian Y, Zuo ZL, Fang P, Chung AC, Hou FF, Cheng YX (2015) Lingzhilactones from Ganoderma lingzhi ameliorate adriamycin-induced nephropathy in mice. J Ethnopharmacol 176:385–393PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL (2012) Doxorubicin- induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 52(6):1213–1225PubMedCrossRefGoogle Scholar
  37. 37.
    Sudheesh NP, Ajith TA, Janardhanan KK (2013) Ganoderma lucidum ameliorate mitochondrial damage in isoproterenol-induced myocardial infarction in rats by enhancing the activities of TCA cycle enzymes and respiratory chain complexes. Int J Cardiol 165(1):117–125PubMedCrossRefGoogle Scholar
  38. 38.
    Veena RK, Ajith TA, Janardhanan KK (2018) Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (Agaricomycetes), prevents Doxorubicin- induced cardiotoxicity in rats. Int J Med Mushrooms 20(8):761–774PubMedCrossRefGoogle Scholar
  39. 39.
    Xu F, Li X, Xiao X, Liu LF, Zhang L, Lin PP, Zhang SL, Li QS (2017) Effects of Ganoderma lucidum polysaccharides against doxorubicin-induced cardiotoxicity. Biomed Pharmacother 95:504–512CrossRefGoogle Scholar
  40. 40.
    Kensler TW, Wakabayashi N, Biswal S (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47:89–116PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Rajasekaran M, Kalaimagal C (2012) Cardioprotective effect of a medicinal mushroom, Ganoderma lucidum against Adriamycin induced toxicity. Int J Pharmacol 8(4):252–254CrossRefGoogle Scholar
  42. 42.
    Poon KS, Un MK, Low XH, Cheung YT, Yap KY, Chan A (2013) Impact of cancer-related fatigue on chemotherapy-induced nausea and vomiting in Asian cancer patients. Pharmacoepidemiol Drug Saf 22(12):1345–1351PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S (2012) Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav Immun 26(5):706–713PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C (2015) Cancer-related fatigue, Version 2.2015. J Natl Compr Canc Netw 13(8):1012–1039PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Iwase S, Kawaguchi T, Tokoro A, Yamada K, Kanai Y, Matsuda Y, Kashiwaya Y, Okuma K, Inada S, Ariyoshi K, Miyaji T, Azuma K, Ishiki H, Unezaki S, Yamaguchi T (2015) Assessment of cancer-related fatigue, pain, and quality of life in cancer patients at palliative care team referral: a multicenter observational study (JORTC PAL-09). Plos One 10(8):e134022CrossRefGoogle Scholar
  46. 46.
    Bao PP, Lu W, Cui Y, Zheng Y, Gu K, Chen Z, Zheng W, Shu XO (2012) Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. Plos One 7(6):e39343PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Pan K, Jiang Q, Liu G, Miao X, Zhong D (2013) Optimization extraction of Ganoderma lucidum polysaccharides and its immunity and antioxidant activities. Int J Biol Macromol 55:301–306PubMedCrossRefGoogle Scholar
  48. 48.
    Ouyang MZ, Lin LZ, Lv WJ, Zuo Q, Lv Z, Guan JS, Wang ST, Sun LL, Chen HR, Xiao ZW (2016) Effects of the polysaccharides extracted from Ganoderma lucidum on chemotherapy-related fatigue in mice. Int J Biol Macromol 91:905–910PubMedCrossRefGoogle Scholar
  49. 49.
    McKenzie E, Zaki P, Raman S, Olson R, McFarlane T, DeAngelis C, Chan S, Pidduck W, Razvi Y, Bushehri A, Chow E (2019) Radiation-induced nausea and vomiting: a comparison between MASCC/ESMO, ASCO, and NCCN antiemetic guidelines. Support Care Cancer 27(3):783–791PubMedCrossRefGoogle Scholar
  50. 50.
    Kovac AL (2003) Benefits and risks of newer treatments for chemotherapy-induced and postoperative nausea and vomiting. Drug Saf 26(4):227–259PubMedCrossRefGoogle Scholar
  51. 51.
    Horneber M, van Ackeren G, Fischer F, Kappauf H, Birkmann J (2018) Addressing unmet information needs: results of a clinician-led consultation service about complementary and alternative medicine for cancer patients and their relatives. Integr Cancer Ther 17(4):1172–1182PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Wang CZ, Basila D, Aung HH, Mehendale SR, Chang WT, McEntee E, Guan X, Yuan CS (2005) Effects of Ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med 33(5):807–815PubMedCrossRefGoogle Scholar
  53. 53.
    Wang DH, Weng XC (2006) Antitumor activity of extracts of 53. Ganoderma lucidum and their protective effects on damaged HL-7702 cells induced by radiotherapy and chemotherapy. China J Chin Mat Media 31(19):1618–1622Google Scholar
  54. 54.
    Lin ZB (2011) Multi-target anti-tumor effect of Ganoderma lucidum and its research. Li xuejun editor-in-chief. Multi-target drug research and application. People’s Health Publishing Press, Beijing, pp 479–489Google Scholar
  55. 55.
    Liang J, Li YR, Wang SW (2002) Effect of radiotherapy combined with a medicine Lingzhi-912 on treatment of esophageal cancer. J Fourth Mil Med Univ 23(3):278–280Google Scholar
  56. 56.
    Zhuang SR, Chiu HF, Chen SL, Tsai MY, Lee MY, Lee HS, Shen YC, Yan YY, Shane GT, Wang CK (2012) Effects of a Chinese medical herbs complex on cellular immunity and toxicity-related conditions of breast cancer patients. Br J Nutr 107(5):712–714PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Zhao FY, Wu Q, Li YM, Wang R (2015) Efficacy of Ganoderma lucidum spore capsule combined with chemotherapy in the treatment of non-small cell lung cancer and its effect on immune function. Chin J Gerontol 35(10):2721–2722Google Scholar
  58. 58.
    Wang J, Chen ZQ, Li Y, Wang XS, Fei CL, Wang XJ (2016) Clinical effect of compound Ganoderma lucidum spore capsule combined with chemotherapy on non-small cell lung cancer and its effect on immune function. Mod J Integr Tradit Chin West Med 25(24):2673–2675Google Scholar
  59. 59.
    Yan BK, Wei YJ, Li YQ (1998) Effect of Lao Jun Xian Lingzhi oral liquid combined with chemotherapy on advanced non-small cell lung cancer at stages II and III. Tradit Chin Drug Res Pharmacol 9(2):13–16Google Scholar
  60. 60.
    Yu Y (2001) Effects of Ganoderma spore powder on peripheral blood cells of cancer patients. J Liao Ning Coll Tradit Chin Med 3(3):173Google Scholar
  61. 61.
    Sun DJ, Li W, Zhang WG, Wei QL (1999) Clinical observation on the efficacy of Lingzhi Fuzheng capsule in reducing toxicity and enhancing efficacy of radiotherapy and chemotherapy for malignant tumors. J Binzhou Med Univ 22(2):40–42Google Scholar
  62. 62.
    Qi YF, Li XR, Yan M (1999) Ganoderma spore powder adjuvant chemotherapy for digestive system tumors clinical observation. Chin J Integr Med 19(9):554–555Google Scholar
  63. 63.
    Kuang JM, Wang JW, Kuang JM (2007) Clinical Observation on the curative effect of broken Ganoderma spore powder combined with chemotherapy for malignant tumor. Shandong Med J 47(21):59–60Google Scholar
  64. 64.
    Wang YH, Qu ZH, Qin Y (2014) Clinical observation of broken Ganoderma spore powder combined with xeloda and combined with oxaliplatin chemotherapy for advanced colorectal cancer. China Prac Med 9(21):108–109Google Scholar
  65. 65.
    Lin ND, Su JN, Zhu Z, Gao YH, Gao H, Xie GY, Chen B, Ye XY (2004) Analysis on 66 cases of cancer patients treated by chemotherapy with extract of Ganoderma lucidum. J Pract Tradit Chin Intern Med 18(5):457–454Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of Medicine Clinical LaboratoryThe Third Xiangya Hospital of Central South UniversityChangshaChina
  2. 2.Department of PharmacologySchool of Basic Medical Sciences, Peking UniversityBeijingChina

Personalised recommendations